Literature DB >> 20158488

Dextran carrier macromolecule for colon specific delivery of celecoxib.

Prabhat K Shrivastava1, Sushant K Shrivastava.   

Abstract

The colon specific polymeric conjugates of celecoxib were prepared with dextran of different molecular weight Mr approximately 40 000, 70 000, and 100 000 (CSD-40, CSD-70 and CSD-100). Succinic acid was used as linker between the drug and dextran. The prepared conjugates were characterized by UV, IR, 1H NMR and HPLC. The maximum degree of substitution 3.9+/-0.20 % was found with the dextran CSD-100 conjugates. The percent release of drug obtained by in-vitro hydrolysis studies, was found to be 24.37+/- 0.6, 23.0 +/- 0.5 and 20.13+/- 0.8 in simulated colonic fluid (SCF) pH 6.8 while 17.90 +/- 0.4, 16.8+/- 0.75 and 15.47 +/- 0.5 in simulated intestinal fluid (SIF) pH 7.4 for CSD-40, CSD-70 and CSD-100, respectively, in both medium. The drug release from the conjugates was observed for 24 h in 3% w/v rat caecal content and found to be 41.77 +/- 1.2, 39.03 +/- 1.0 and 35.26 +/- 1.09 for CSD-40, CSD-70 and CSD-100 conjugates, respectively. The half life of conjugates was determined and was found to be short in 3% w/v rat caecal content. No amount of drug was released in simulated gastric fluid pH 1.2 and stomach homogenate in 2 h. The amount of drug released from small intestine homogenate was 3.4+/- 0.1 percent in 12 h for the CSD-40. The above result suggests that dextran could be used as a macromolecular carrier for colon specific drug delivery of celecoxib.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158488     DOI: 10.2174/156720110791011828

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  4 in total

Review 1.  Nanomedicine in GI.

Authors:  Hamed Laroui; David S Wilson; Guillaume Dalmasso; Khalid Salaita; Niren Murthy; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-09       Impact factor: 4.052

2.  A review on composite liposomal technologies for specialized drug delivery.

Authors:  Maluta S Mufamadi; Viness Pillay; Yahya E Choonara; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo
Journal:  J Drug Deliv       Date:  2011-02-08

3.  Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.

Authors:  Yonghyun Lee; Jungyun Kim; Wooseong Kim; Joon Nam; Seongkeun Jeong; Sunyoung Lee; Jin-Wook Yoo; Min-Soo Kim; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2015-07-30       Impact factor: 4.162

4.  Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid.

Authors:  P K Shrivastava; A Shrivastava; S K Sinha; S K Shrivastava
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.